Pancreatic cancer
Open
Phase 2
This trial is looking at treating pancreatic cancer that has spread to another part of the body with pembrolizumab and olaparib.
It is for people who:
can’t have surgery to remove the cancer
have a lot of gene changes (mutations) in the pancreatic cancer cells
Recruitment start: 16 August 2024
Recruitment end: 31 October 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Pippa Corrie
Cambridge University Hospitals NHS Foundation Trust
National Institute of Health Research (NIHR)
Merck Sharp & Dohme
Last reviewed: 16 Apr 2025
CRUK internal database number: 19905
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
